Goodwin-Led Gene Editing Firm Metagenomi Raises $94M IPO
By Yeji Jesse Lee · February 9, 2024, 4:14 PM EST
Preclinical biotech Metagenomi began trading publicly on Friday, raising $94 million by offering 6.25 million shares at $15, the low end of the $15 to $17 range it had set earlier...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login